NEWARK, N.J., Aug. 5 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a specialty chemical technology based Life Science Company announced today independent steel corrosion test results conducted at Criterion Chemical. Following an impartial blind testing protocol Ygiene(TM) Hospital Grade Antimicrobial was found to be completely non-corrosive to steel.
Many of today's commercially available antimicrobials and cleaners are corrosive to iron and steel. As confirmed by this independent test, Ygiene(TM) Hospital Grade Antimicrobial was found to be completely inert and not corrosive while all of the following products tested were found to be corrosive: Lysol(R) Disinfectant All Purpose Cleaner 4N1; Odo Ban(R) Silver Formula Germ Control 24; Clorox(R) Anywhere Hard Surface Daily Sanitizer Spray; Lysol(R) Disinfectant Bathroom Cleaner 4N1; Clorox(R) Regular Bleach; and Green Works(TM) Natural Bathroom Cleaner. Careful steps were taken to treat all the formulations quantitatively equal to maintain standards for independent testing.
Ygiene(TM) was the only antimicrobial to show absolutely no sign of corrosion. All the other solutions exhibited clear signs of chemical reaction with the steel wool, including at least one of the following events: color change in the solution, precipitation of an undetermined substance from the solution, disintegration of the steel wool into filings, deposition on the steel wool, dissolution of the steel wool, effervescence from the steel wool or the filings.
Dr. Samuel D'Arcangelis, PhD, President of Criterion Chemical, stated: "It is truly remarkable that BioNeutral's Ygiene(TM) which contains no corrosion inhibitors was completely inert and showed no signs of corrosion in the twelve day test we conducted."
"This is an important test," said Dr. Andy Kielbania PhD, Chief Scientific Officer of Bioneutral "because of the potential for Ygiene(TM) to be used as a sterilant for medical, dental and surgical instruments as well as its use on ferrous materials which are common in the broader health care field, industrial and consumer environment. It adds a further quality to the rapid sterilizing capabilities of Ygiene(TM) which separates our technology from every competitor."
"Antimicrobials are notoriously corrosive," said Stephen J. Browand BioNeutral Group's CEO. "Commercially, there are many circumstances where a green, inert, sporicidal antimicrobial will be preferred when corrosion is a concern. As an example. medical, dental and surgical instruments are expensive and their usable life is shortened by corrosion. The pharmaceutical industry mixes basic ingredients in large stainless steel vats which can be damaged by corrosive antimicrobials."
About Criterion Chemical LLC:
Criterion Chemical is a specialty chemical company with strong expertise in understanding the reactivity of metals and the mechanism of metallic catalytic processes. In addition Criterion Chemical custom synthesizes new catalyst and has unique processes for metal recovery.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. BioNeutral has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
More information about the Company may be found at www.bioneutralgroup.com.
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how BioNeutral's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the BioNeutral's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene(TM) and are not yet available for sale in the United States.
BioNeutral Group Inc. Stephen J. Browand, President and CEO email@example.com Investor Relations Aimee Boutcher 973 239-2878 firstname.lastname@example.org
|SOURCE BioNeutral Group, Inc.|
Copyright©2009 PR Newswire.
All rights reserved